Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J.P. Morgan Asset Management is the asset management business of JPMorgan Chase & Co., managing over $3.7 trillion in assets across various asset classes globally. While it has dedicated private capital teams, including Life Sciences Private Capital, which invest in the biotech and healthcare sectors, J.P. Morgan Asset Management itself is not a healthcare or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J.P. Morgan Asset Management.